KE3606A - Polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use - Google Patents

Polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use

Info

Publication number
KE3606A
KE3606A KE3606A KE360686A KE3606A KE 3606 A KE3606 A KE 3606A KE 3606 A KE3606 A KE 3606A KE 360686 A KE360686 A KE 360686A KE 3606 A KE3606 A KE 3606A
Authority
KE
Kenya
Prior art keywords
polypeptides
processes
production
pharmaceutical compositions
monocyclic
Prior art date
Application number
KE3606A
Other languages
English (en)
Inventor
Wilfried Bauer
Janos Dr Pless
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of KE3606A publication Critical patent/KE3606A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
KE3606A 1979-11-27 1986-02-10 Polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use KE3606A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1052479 1979-11-27
CH457480 1980-06-13
EP80107181A EP0029579B1 (en) 1979-11-27 1980-11-19 Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use

Publications (1)

Publication Number Publication Date
KE3606A true KE3606A (en) 1986-03-17

Family

ID=25695798

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3606A KE3606A (en) 1979-11-27 1986-02-10 Polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use

Country Status (25)

Country Link
US (1) US4395403A (cs)
EP (1) EP0029579B1 (cs)
JP (1) JPS5690048A (cs)
AT (1) ATE2512T1 (cs)
AU (1) AU543198B2 (cs)
CA (1) CA1182109A (cs)
CS (1) CS228140B2 (cs)
CY (1) CY1327A (cs)
DE (2) DE19375086I2 (cs)
DK (1) DK150146C (cs)
ES (2) ES8301463A1 (cs)
FI (1) FI72981C (cs)
GR (1) GR71636B (cs)
HK (1) HK30686A (cs)
HU (1) HU185920B (cs)
IE (1) IE50571B1 (cs)
IL (1) IL61561A (cs)
KE (1) KE3606A (cs)
LU (1) LU88344I2 (cs)
MY (1) MY8500072A (cs)
NL (1) NL930137I2 (cs)
NZ (1) NZ195640A (cs)
PH (1) PH22841A (cs)
PT (1) PT72103B (cs)
SG (1) SG8786G (cs)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
CH655505B (cs) * 1982-08-24 1986-04-30
US4663435A (en) * 1982-12-06 1987-05-05 Merck & Co., Inc. Bridged cyclic hexapeptide somatostatin analogs
FR2554347B1 (fr) * 1983-11-07 1986-10-03 Immunotech Sa Acide pressinique, ses derives aminoacides substitues et homologues de configuration d ainsi que les derives n- et c- terminal-substitues et leurs applications dans les domaines therapeutique, biologique ou immunologique
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
GB8620035D0 (en) * 1986-08-18 1986-10-01 Sandoz Ltd Organic compounds
GB2193891B (en) * 1986-08-18 1990-07-25 Sandoz Ltd Nasal pharmaceutical composition containing a somatostatin anologue.
DE3790635B4 (de) * 1986-10-13 2007-11-22 Novartis Ag Verfahren zur Herstellung eines Peptidalkohols und Ausgangsverbindungen dafür
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
NO893088L (no) * 1988-08-18 1990-02-19 Syntex Inc Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.
US5006510A (en) * 1989-06-20 1991-04-09 Ellis Wladislaw V Method for relieving chronic pain with a somatostatin analog composition
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
US5084443A (en) * 1989-12-04 1992-01-28 Biomeasure, Inc. Promoting expression of acetylcholine receptors with lhrh antagonist
EP0457888B1 (en) * 1989-12-08 1996-07-10 The Administrators of The Tulane Educational Fund Octapeptide analogs of somatostatin having threonine at the sixth position
DK0542934T3 (da) * 1991-02-08 1999-11-22 Biomeasure Inc Anvendelse af somatostatinanaloger til behandling af melanomer
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
GB9402767D0 (en) * 1994-02-14 1994-04-06 Sandoz Ltd Improvements in or relating to organic compounds
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
EP0824103A1 (en) * 1996-08-13 1998-02-18 Chang-Shinn Su Method for synthesis of Tyr-3-octreotide
US6262229B1 (en) 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
ATE245998T1 (de) * 1997-05-13 2003-08-15 Sod Conseils Rech Applic Somatostatin agoniste zur reduzierung von körpergewicht
WO1998051330A1 (en) * 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
DK0980253T3 (da) * 1997-05-13 2004-07-05 Sod Conseils Rech Applic Somatostatin og somatostatinagonister til behandling af insulininsensitivitet og syndrom X
ES2144357B1 (es) 1998-01-29 2000-12-16 Lipotec Sa Procedimiento para la obtencion del analogo de somatostatina octreotide.
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
US6159935A (en) 1999-11-29 2000-12-12 Pharmacia & Upjohn Co. Method for preventing diarrhea
RU2196144C1 (ru) * 2001-05-14 2003-01-10 Самуков Владимир Васильевич Защищенные производные октреотида
JP3996897B2 (ja) 2001-06-08 2007-10-24 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス ソマトスタチン−ドーパミンキメラ類似体
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
US6987167B2 (en) 2002-05-22 2006-01-17 Wockhardt Limited Process for production of the somatostatin analog, octreotide
US20040097419A1 (en) 2002-11-19 2004-05-20 Holger Petersen Organic compounds
ATE334998T1 (de) * 2003-04-07 2006-08-15 Novetide Ltd Verfahren zur herstellung cyclischer peptide
SG173223A1 (en) 2003-04-22 2011-08-29 Ipsen Pharma Sas Peptide vectors
ATE469912T1 (de) * 2004-10-04 2010-06-15 Novetide Ltd Gegenionenaustauschverfahren für peptide
PT1968549E (pt) 2005-12-22 2014-08-29 Novartis Ag Formulação de libertação controlada compreendendo octreotida e dois ou mais polímeros de polilactídeo-co-glicolídeo
EP2013226A2 (en) * 2006-03-28 2009-01-14 Wockhardt Limited Processes for the preparation of octreotide
TW200819137A (en) * 2006-10-31 2008-05-01 Iner Aec Executive Yuan Method for preparation of lipid-spacer radical- reactions of functional group-peptide
US20090082259A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched octreotide
EP2213307A1 (en) 2009-02-03 2010-08-04 Novartis AG Injectable depot formulations
EP2172189A1 (en) 2008-10-01 2010-04-07 Novartis AG Pharmaceutical Compositions
WO2010089757A2 (en) 2008-11-07 2010-08-12 Usv Limited An improved process for synthesis of cyclic octapeptide
WO2010093243A1 (en) 2009-02-12 2010-08-19 Coöperatieve Mirzorg U.A., Arnhem Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
US20140296144A1 (en) 2011-09-30 2014-10-02 Mylan Laboratories, Ltd. Process for the preparation of octreotide acetate
CN103102390B (zh) * 2011-11-09 2015-01-28 杭州华津允上医药有限公司 一种奥曲肽的制备方法
WO2013132505A1 (en) 2012-03-09 2013-09-12 Natco Pharma Limited Improved process for preparation of octreotide by solution phase peptide synthesis
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法
CN108395469A (zh) * 2018-02-01 2018-08-14 滨海吉尔多肽有限公司 一种假脯氨酸二肽的合成方法
GB202012334D0 (en) 2020-08-07 2020-09-23 Avon Polymer Prod Ltd Monitoring system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105603A (en) * 1977-03-28 1978-08-08 The Salk Institute For Biological Studies Peptides which effect release of hormones
US4140767A (en) * 1977-12-01 1979-02-20 Merck & Co., Inc. Somatostatin analogs
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity
US4225472A (en) * 1979-05-29 1980-09-30 American Home Products Corporation Truncated somatostatin analogs
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone

Also Published As

Publication number Publication date
ES8305701A1 (es) 1983-04-16
ES497113A0 (es) 1982-12-01
PT72103B (fr) 1982-01-28
GR71636B (cs) 1983-06-20
JPS5690048A (en) 1981-07-21
IL61561A0 (en) 1980-12-31
CA1182109A (en) 1985-02-05
FI72981B (fi) 1987-04-30
EP0029579A1 (en) 1981-06-03
DE19375086I2 (de) 2003-01-09
PH22841A (en) 1989-01-19
EP0029579B1 (en) 1983-02-16
ES8301463A1 (es) 1982-12-01
ES510751A0 (es) 1983-04-16
FI72981C (fi) 1987-08-10
IE50571B1 (en) 1986-05-14
HU185920B (en) 1985-04-28
CS228140B2 (en) 1984-05-14
DK501980A (da) 1981-05-28
NZ195640A (en) 1984-07-06
ATE2512T1 (de) 1983-03-15
JPS6351159B2 (cs) 1988-10-13
AU543198B2 (en) 1985-04-04
MY8500072A (en) 1985-12-31
IE802452L (en) 1981-05-27
LU88344I2 (fr) 1994-05-04
SG8786G (en) 1987-03-27
AU6468880A (en) 1981-06-04
CY1327A (en) 1986-06-27
US4395403A (en) 1983-07-26
DE3062075D1 (en) 1983-03-24
DK150146B (da) 1986-12-15
NL930137I2 (nl) 1997-02-03
NL930137I1 (nl) 1993-11-01
HK30686A (en) 1986-05-09
IL61561A (en) 1985-02-28
DK150146C (da) 1987-06-01
FI803634L (fi) 1981-05-28
PT72103A (fr) 1980-12-01

Similar Documents

Publication Publication Date Title
DE3062075D1 (en) Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
ZA8410044B (en) Peptide production and use thereof
IL60185A (en) 6 beta,7 beta;15,16-dimethylene-1,4-androstadien-3-ones,process for their production and pharmaceutical preparations containing them
DE3061733D1 (en) Novel heterocyclic substituted pyrazinoylguanidines, processes for preparing and a pharmaceutical composition containing the same
IL94465A0 (en) Substituted(quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides,processes for their preparation and pharmaceutical compositions containing them
EP0155786A3 (en) New peptide, and production and use thereof
DE3568048D1 (en) Process for the synthesis of peptides
GB2125799B (en) Novel polypeptides processes for their production pharmaceutical compositions comprising said polypeptides and their use
GB1508682A (en) Peptide intermediates
GB1361779A (en) Vincamine salt and its use as a pharmaceutical composition
DE3275375D1 (en) Mercapto amino acids, process for their preparation and pharmaceutical compositions containing them
ZA807421B (en) Novel polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
YU43880A (en) Process for the chlorination of the carboxy group of amino acids
JPS52108086A (en) Preparation of alpha-keto-acid